Abbott to Split Into Two, Focusing on Drug Areas

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Oct. 19 (Bloomberg) -- Abbott Laboratories, the maker of infant formula, heart stents and prescription drugs, will split into two companies, with one selling generic drugs and medical devices and the other research-based medicines. Shannon Pettypiece reports on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change